期刊
CELLS
卷 11, 期 1, 页码 -出版社
MDPI
DOI: 10.3390/cells11010010
关键词
Autism Spectrum Disorder (ASD); whole genome sequencing; whole exome sequencing; sanger sequencing; genetic report; trios; pathogenic variants; bioinformatics pipeline; precision medicine; molecular diagnostics
类别
This study demonstrates the clinical feasibility and technical implementation of a WGS genetic report for patients with ASD. By using WGS data from six family trios and considering clinical symptoms and literature review, an evidence-based and transparent bioinformatics pipeline and report framework were provided. This method can contribute to a better understanding of ASD pathophysiology, early detection of associated comorbidities, and personalized treatment based on genetic information.
Autism spectrum disorder (ASD) is a neurodevelopmental disorder with strong genetic influences. There is an increasing demand for ASD genetic testing beyond the traditionally recommended microarray and syndromic autism testing; however, the current whole genome sequencing (WGS) and whole exome sequencing (WES) methods are lacking an academic standard for WGS variant annotation, reporting, and interpretation, tailored towards patients with ASD and offer very limited interpretation for clinical significance. Using WGS data from six family trios, we demonstrate the clinical feasibility and technical implementation of an evidence-based, fully transparent bioinformatics pipeline and report framework for an ASD-focused WGS genetic report. We confirmed a portion of the key variants with Sanger sequencing and provided interpretation with consideration of patients' clinical symptoms and detailed literature review. Furthermore, we showed that identification of the genetic contributions of ASD core symptoms and comorbidities may promote a better understanding of the ASD pathophysiology, lead to early detection of associated comorbidities, and facilitate pharmacologic intervention based on pathological pathways inferred from the genetic information. We will make the bioinformatics pipeline and interpretation framework publicly available, in an easily accessible format, after validation with a larger cohort. We hope that the present proposed protocol can serve as a starting point to invite discourse and debate to further improve approaches in WGS-based genetic consultation for patients with ASD.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据